gw pharma ceo: europe epidyolex launch | mad money | cnbc
Published 4 years ago • 759 plays • Length 7:03Download video MP4
Download video MP3
Similar videos
-
1:59
epidiolex sales, potential cbd treatment for ptsd and more: gw pharma ceo
-
6:33
gw pharmaceuticals ceo: pot play | mad money | cnbc
-
2:12
gw pharma ceo explains company's plan for cbd-based epilepsy drug
-
7:28
gw pharmaceuticals ceo: defining cbd and thc-based drugs | mad money | cnbc
-
8:08
gw pharmaceuticals ceo: ‘real science’ in cannabis | mad money | cnbc
-
5:26
trade it or fade it: the week's big biotech moves
-
6:58
aurinia pharmaceuticals ceo: speculative savior? | mad money | cnbc
-
8:41
unilever ceo: enormous returns | mad money | cnbc
-
7:12
gw pharmaceuticals ceo: a ‘big step’ forward | mad money | cnbc
-
7:34
gw pharmaceuticals ceo: cannabis as a cure | mad money | cnbc
-
4:39
gw pharma ceo on new cannabis-derived drug
-
2:03
gw pharma ceo talks epidiolex sales amid the pandemic
-
7:31
gw pharma to launch first cbd-based epilepsy drug in europe 'over the next year or two,' ceo says
-
1:04
gw pharma ceo: need to know more on benefits of cannabis-derived drugs
-
5:56
corbus pharmaceuticals ceo: a big leap | mad money | cnbc
-
4:15
jim cramer on jazz pharmaceuticals buying gw pharma for $7.2 billion
-
8:45
jim cramer on pot - gw pharma
-
6:14
intarcia therapeutics ceo: holy grail of disease treatment | mad money | cnbc
-
2:50
cramer's lightning round: cannabis etfs have pulled down gw pharma
-
6:34
regeneron pharmaceuticals ceo: changing medicine | mad money | cnbc
-
1:04
jazz pharmaceuticals buys gw pharma for $7.2 billion